Stonebridge Capital Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Stonebridge Capital Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-664	Closed	-$1K	–	901
2019 Q4	$1K	Hold	664	–	–	﹤0.01%	837
2019 Q3	$0	Hold	664	–	–	﹤0.01%	988
2019 Q2	$0	Buy	+664	New	+$332	﹤0.01%	949

Stonebridge Capital Advisors's GCVRZ Position: Q1 2020 in Review

Stonebridge Capital Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 664 shares — an estimated $1K sold.

Stonebridge Capital Advisors first reported a position in GCVRZ in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Stonebridge Capital Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Stonebridge Capital Advisors sold 664 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
Stonebridge Capital Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2019 and held it in 3 quarters.
Stonebridge Capital Advisors's Sanofi Contingent Value Rights position peaked at $1K in Q4 2019.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2020, filed 15 May 2020.